Nano Dimension Ltd is trading 5.3% up today at $1.29 after management publicly defended its planned $890 million all-stock acquisition of Infinite Epigenetics and pushed back on dilution concerns raised by activist investor Murchinson.
- The rebound follows a steep two-day slide triggered by the June 15 strategic pivot announcement and the subsequent June 16 activist backlash.
- Management's defense aims to reassure shareholders regarding the AI-driven healthcare pivot as the market weighs long-term growth against immediate dilution risks.
- Investors are currently reassessing the company's new strategic direction while broader market conditions remain mixed.